Alphabet in July, after serving as CFO at pharmaceutical company Eli Lilly for three years. At a tech conference earlier this ...

INDIANAPOLIS - Eli Lilly and Company (NYSE: NYSE:LLY) announced today that Anat Ashkenazi has resigned from her position as Chief... Alphabet (NASDAQ:GOOGL) has appointed Anat Ashkenazi as its new ...

Eli Lilly has called on financial regulators ... The issue was also alluded to by Lilly’s chief financial officer, Anat Ashkenazi, on the company’s fourth-quarter results call yesterday ...

LONDON (Reuters) - Shares in Novo Nordisk (NYSE:NVO), maker of the wildly popular obesity drug Wegovy, were down 1.9% on Tuesday ...

An Eli Lilly exec said the company’s experimental weight-loss pill could make GLP-1 treatments more accessible worldwide, as it would be easier to manufacture and distribute globally.

Late-breaking results from Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) found adolescent patients (ages 12 to under 18) with severe alopecia areata (AA) treated with once-daily ...

The weight loss potential is not exactly there to match the likes of Eli Lilly’s tirzepatide or Novo Nordisk’s CagriSema which has an amylin analog as a “performance enhancer” on top of ...

March 12, 2025 Lilly, J&J boosted spending on executive security after UnitedHealth shooting U.S. drugmakers Johnson & Johnson and Eli Lilly increased spending on security for their top executives ...

CFO Anat Ashkenazi highlighted that a significant portion of the company’s investments has been directed toward technical infrastructure, particularly in expanding its server and data center ...